| |
| |
NEW ON THE MARKET
|
| |
Risperidone (RISPERDAL)-derivative paliperidone (INVEGA) for schizophrenia
|
| |
| |
RECOMMENDATIONS
|
| |
Anticoagulants lower risk of embolism in patients with atrial fibrillation aged over 75
Chronic venous ulcer: simple non adhesive dressings suffice
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Multiple sclerosis - starting therapy before final diagnosis?
|
 |
Aspirin/dipyridamole-combination (AGGRENOX): acquiring highest degree of recommendation?
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Nitrates for angina pectoris: PETN (e.g. PENTALONG) without tolerance?
JACUTIN PEDICUL fluid (Dimethicone) for head lice
|
| |
| |
BEWARE MISINFORMATION
|
| |
Rimonabant (ACOMPLIA) and suicidality: press release of Sanofi Aventis plays down the risk
Misleading advertisement for cabergoline-generics
|
| |
| |
IN BRIEF
|
| |
Influenza vaccines for the season 2007/08
Antidiabetics: call for studies with clinical endpoints
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Fibrohistiocytoma due to insulin glargin (LANTUS)
|
| |
| |
SIDE EFFECTS
|
| |
Lumiracoxib (PREXIGE) off market in Australia because of hepatic damage
|
| |